Qube Research & Technologies LTD Kempharm, Inc Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.12 - $5.62 $34,715 - $47,354
8,426 Added 38.59%
30,259 $138,000
Q3 2022

Nov 14, 2022
SELL
$4.5 - $6.85 $13,576 - $20,666
-3,017 Reduced 12.14%
21,833 $136,000
Q2 2022

Aug 15, 2022
BUY
$4.02 - $5.21 $99,896 - $129,468
24,850 New
24,850 $111,000

Others Institutions Holding KMPH

# of Institutions
116
Shares Held
26.1M
Call Options Held
591K
Put Options Held
242K
View Full List

About KEMPHARM, INC

KMPH Quotes by TradingView
  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email